title: Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective.
authors.affiliation: Augmentium Pharma Consulting, Toronto, ON, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Dranitsaris
authors.affiliation: Fudan University Shanghai Cancer Center, Shanghai, China.
authors.forename: B
authors.initials: B
authors.lastname: Yu
authors.affiliation: Fudan University Shanghai Cancer Center, Shanghai, China.
authors.forename: L
authors.initials: L
authors.lastname: Wang
authors.affiliation: Cancer Hospital of CAMS, Beijing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Peng
authors.affiliation: Jiangsu Provincial Cancer Hospital, Jiangsu, China.
authors.forename: W
authors.initials: W
authors.lastname: Sun
authors.affiliation: Shanghai Centennial Scientific, Shanghai, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhou
authors.affiliation: Celgene Corporation, Summit, NJ, USA.
authors.forename: J
authors.initials: J
authors.lastname: King
authors.affiliation: Celgene Corporation, Summit, NJ, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kaura
authors.affiliation: Celgene Corporation, Summit, NJ, USA.
authors.forename: A
authors.initials: A
authors.lastname: Zhang